Synonyms: Example 152 [WO2020228756A1]
Compound class:
Synthetic organic
Comment: This is the chemical structure for the INN resencatinib. The structure is claimed in patent WO2020228756A1, as a RET receptor tyrosine kinase inhibitor [1]. RET is a proto-oncogene that's implicated in the development of many cancers (including breast cancer, gastric cancer, bowel cancer, thyroid carcinomas, NSCLC, and chronic myelomonocytic leukemia), and its inhibition is a validated anti-tumour mechanism.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Download 2D Structure ![]() |
|
Canonical SMILES | Download |
Isomeric SMILES | Download |
InChI standard identifier | Download |
InChI standard key | Download |
Molecular structure representations generated using Open Babel